# Edoxaban for TIA and Acute Minor Stroke

> **NCT02221102** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Xijing Hospital** · enrollment: 3700 (estimated)

## Conditions studied

- Ischemia
- Stroke
- Cerebral Infarction

## Interventions

- **DRUG:** Aspirin
- **DRUG:** edoxaban
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02221102
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-12
- **Primary completion:** 2015-06
- **Final completion:** 2016-06
- **Target enrollment:** 3700 (ESTIMATED)
- **Last updated:** 2014-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02221102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02221102, "Edoxaban for TIA and Acute Minor Stroke". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02221102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*